FR2362636A1 - Composition therapeutique pour le traitement des etats d'hypertension - Google Patents

Composition therapeutique pour le traitement des etats d'hypertension

Info

Publication number
FR2362636A1
FR2362636A1 FR7725671A FR7725671A FR2362636A1 FR 2362636 A1 FR2362636 A1 FR 2362636A1 FR 7725671 A FR7725671 A FR 7725671A FR 7725671 A FR7725671 A FR 7725671A FR 2362636 A1 FR2362636 A1 FR 2362636A1
Authority
FR
France
Prior art keywords
therapeutic composition
treatment
dose
beta
hypertension conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7725671A
Other languages
English (en)
French (fr)
Other versions
FR2362636B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm Pharma GmbH
Original Assignee
Roehm Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma GmbH filed Critical Roehm Pharma GmbH
Publication of FR2362636A1 publication Critical patent/FR2362636A1/fr
Application granted granted Critical
Publication of FR2362636B1 publication Critical patent/FR2362636B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7725671A 1976-08-27 1977-08-23 Composition therapeutique pour le traitement des etats d'hypertension Granted FR2362636A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762638716 DE2638716A1 (de) 1976-08-27 1976-08-27 Antihypertensiva

Publications (2)

Publication Number Publication Date
FR2362636A1 true FR2362636A1 (fr) 1978-03-24
FR2362636B1 FR2362636B1 (ja) 1980-12-05

Family

ID=5986558

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7725671A Granted FR2362636A1 (fr) 1976-08-27 1977-08-23 Composition therapeutique pour le traitement des etats d'hypertension

Country Status (4)

Country Link
JP (1) JPS5350340A (ja)
DE (1) DE2638716A1 (ja)
FR (1) FR2362636A1 (ja)
GB (1) GB1584089A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions
DE3016818A1 (de) * 1980-05-02 1982-02-04 Röhm Pharma GmbH, 6100 Darmstadt Diagnostisches verfahren zur bestimmung der leberfunktion
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung
EP0081006B1 (en) * 1981-12-08 1985-09-25 Smithkline Beckman Corporation Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT336176B (de) 1971-12-10 1977-04-25 Sandoz Ag Verfahren zur herstellung eines pharmazeutischen praparates

Also Published As

Publication number Publication date
GB1584089A (en) 1981-02-04
JPS5350340A (en) 1978-05-08
DE2638716A1 (de) 1978-03-02
FR2362636B1 (ja) 1980-12-05

Similar Documents

Publication Publication Date Title
FR2362636A1 (fr) Composition therapeutique pour le traitement des etats d'hypertension
FR2357303A1 (fr) Procede pour la production selective de benzene para-dialkyle substitue et catalyseur convenant a cette fin
KR890012644A (ko) 간 장해 치료제
FR2397682A1 (fr) Procede et dispositif pour la construction d'une image par tomographie
GB1473078A (ja)
Nolan Acute suicidal depression associated with use of timolol
JPS5714589A (en) Benzothiazine derivative, its preparation and drug composition
FR2329010A1 (fr) Dispositif reducteur de pression avec stabilisation directe de la pression reduite d'aval
Rowland et al. The effects of topical prazosin on normal and elevated intraocular pressure and blood pressure in rabbits
FR2358837A1 (fr) Aliment melange contenant un antibiotique et des enzymes, pour animaux d'elevage
Vandenbroucke Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide?
Luthra et al. Lack of association of HLA‐A and B locus antigens with relapsing polychondritis
GB1304978A (ja)
USD225448S (en) Lighter
JPS55113721A (en) Immunity regulator
JPS5757863A (en) Heat resistant conveying roller
Mitra et al. Menstrual disorder after medical termination of pregnancy
USD163936S (en) De marzi
USD95452S (en) Design for an apron
USD151525S (en) Combined fireplace screen and fender
USD202312S (en) Combination aircraft
USD224828S (en)
USD219255S (en) Jacket
USD167275S (en) Pendant cross
FR2092780A2 (en) 2-oxa-3-oxo-17-beta undecanoyloxy estra-4,9,11-triene - - long acting anabolic agent